Results 161 to 170 of about 19,267,272 (276)

Coronary atherectomy in acute ischemic syndromes: Implications of thrombus on treatment outcome

, 1991
Barry Kramer, Timothy J. Larkin, Paulette Niemyski, Michele Parker   +3 more
openalex   +1 more source

Total Ischaemic Burden European Trial (TIBET): Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina [PDF]

, 1996
Henry J. Dargie, Ian Ford, Kim Fox
openalex   +1 more source

Microsatellite-high intrahepatic cholangiocarcinoma with favorable treatment outcome using pembrolizumab. [PDF]

Clin J Gastroenterol
Horiguchi S, Kato H, Miyamoto K, Morimoto K, Matsumi A, Terasawa H, Fujii Y, Matsumoto K, Tanaka T, Otsuka M.   +9 more
europepmc   +1 more source

Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction value

Molecular Oncology, EarlyView.
The Unsupervised AML Multi‐Omics Classification System (UAMOCS) integrates genomic, methylation, and transcriptomic data to categorize AML patients into three subtypes (UAMOCS1‐3). This classification reveals clinical relevance, highlighting immune and chromosomal characteristics, prognosis, and therapeutic vulnerabilities.
Yang Song, Zhe Wang, Guangji Zhang, Jiangxue Hou, Kaiqi Liu, Shuning Wei, Yan Li, Chunlin Zhou, Dong Lin, Min Wang, Hui Wei, Jianxiang Wang, Tao Cheng, Yingchang Mi   +13 more
wiley   +1 more source

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome [PDF]

, 1999
TG Gross, M. Steinbuch, Todd E. DeFor, RS Shapiro, Philip B. McGlave, NKC Ramsay, JE Wagner, A.H. Filipovich   +7 more
openalex   +1 more source

Predictors of tuberculosis treatment outcome at Senkatana clinic in Lesotho. [PDF]

Pan Afr Med J
Kabuya RM, Musekiwa A, Takuva S, Thabane L, Mbuagbaw L.   +4 more
europepmc   +1 more source

Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
We aggregated a cohort of 1012 mCRPC tissue samples from 769 patients and investigated the association of gene expression‐based pathways with clinical outcomes. Loss of AR signaling, high proliferation, and a glycolytic phenotype were independently prognostic for poor outcomes, and an adverse transcriptional feature score incorporating these pathways ...
Marina N. Sharifi, Eric Feng, Nicholas R. Rydzewski, Amy K. Taylor, Jamie M. Sperger, Yue Shi, Kyle T. Helzer, Matthew L. Bootsma, Viridiana Carreno, Alex H. Chang, Luke A. Nunamaker, Grace C. Blitzer, Tianfu Andy Shang, Aishwarya Subramanian, Anders Bjartell, Andreas Josefsson, Pernilla Wikström, Emily Feng, Manish Kohli, Rendong Yang, Scott M. Dehm, Eric J. Small, Rahul Aggarwal, David A. Quigley, Joshua M. Lang, Shuang G. Zhao, Martin Sjöström   +26 more
wiley   +1 more source

Role of Psychosocial Treatments in Management of Schizophrenia: A Meta-Analytic Review of Controlled Outcome Studies [PDF]

, 1998
Ramin Mojtabai, R. Nicholson, B. N. Carpenter   +2 more
openalex   +1 more source

Subtle changes on electrocardiogram in severe patients with COVID-19 may be predictors of treatment outcome. [PDF]

Front Artif Intell
Chaikovsky I, Dziuba D, Kryvova O, Marushko K, Vakulenko J, Malakhov K, Loskutov О.   +6 more
europepmc   +1 more source

TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis

Molecular Oncology, EarlyView.
TOMM20 increases cancer aggressiveness by maintaining a reduced state with increased NADH and NADPH levels, oxidative phosphorylation (OXPHOS), and apoptosis resistance while reducing reactive oxygen species (ROS) levels. Conversely, CRISPR‐Cas9 knockdown of TOMM20 alters these cancer‐aggressive traits.
Ranakul Islam, Megan E. Roche, Zhao Lin, Diana Whitaker‐Menezes, Victor Diaz‐Barros, Eurico Serrano, Maria Paula Martinez Cantarin, Nancy J. Philp, Atrayee Basu Mallick, Ubaldo Martinez‐Outschoorn   +9 more
wiley   +1 more source